LearnDrugs.com
Immune / Anti-infective

Macrolides

High-yield Verified · Jul 2026

Prototype: azithromycin

Azithromycin and relatives — bacteriostatic 50S inhibitors recognizable by the -thromycin stem.

How it works in the body

The system involved, what goes wrong, and how the drug and body interact.

01 The other ribosome-blocker — and why it’s a PCN-allergy staple

Like aminoglycosides, macrolides inhibit bacterial protein synthesis — but they bind the 50S subunit (the other half of the ribosome) and are usually bacteriostatic (they stop growth rather than kill outright). Their spectrum covers many Gram-positive and atypical respiratory organisms (Mycoplasma, Chlamydia, Legionella, pertussis).

Because they don’t contain a beta-lactam ring, macrolides are a common alternative for penicillin-allergic patients — a high-yield fact. Azithromycin is especially convenient: a long half-life allows short courses (the "Z-Pak").

Macrolides bind the 50S subunit and block translocation → bacteriostatic.

02 The two safety themes — the heart and the liver enzymes

Two issues run through the class. First, macrolides prolong the QT interval and can trigger the dangerous arrhythmia torsades de pointes — a risk that climbs with other QT drugs, low potassium/magnesium, or existing heart disease. Second, erythromycin and clarithromycin inhibit CYP3A4, the liver enzyme that clears many drugs — so they raise levels of statins, warfarin, certain calcium-channel blockers, and more (clarithromycin is the strongest inhibitor; azithromycin barely does this, making it the safer choice for interactions).

Erythromycin has a third quirk: it stimulates gut motilin receptors, so it strongly speeds gastric emptying — useful as a prokinetic, but the cause of its frequent GI cramping, nausea, and diarrhea.

Two class effects to anticipate: QT prolongation and (erythro/clarithro) CYP3A4 inhibition.

Drug names

Generic Brand
azithromycin Zithromax, Z-Pak
clarithromycin Biaxin
erythromycin Ery-Tab

Indications

  • Community-acquired pneumonia and atypical respiratory infections (Mycoplasma, Chlamydia, Legionella)
  • Streptococcal pharyngitis / skin infections in penicillin-allergic patients
  • Pertussis, chlamydia (azithromycin single dose), H. pylori (clarithromycin regimens)

Mechanism of action

Bind the 50S bacterial ribosomal subunit and block translocation, inhibiting protein synthesis — generally bacteriostatic. Erythromycin and clarithromycin also inhibit hepatic CYP3A4; erythromycin stimulates motilin (prokinetic effect).

In plain terms
They stop bacteria from building the proteins they need to grow — and serve as a penicillin substitute.

Therapeutic effects — what you'll see working

Success is resolution of the respiratory or soft-tissue infection. The nursing focus is anticipating the QT and drug-interaction risks before they cause harm.

Halts bacterial growth Penicillin-allergy coverage
Halts bacterial growth
Bacteriostatic inhibition of protein synthesis clears susceptible respiratory, skin, and atypical infections; the host immune system finishes the job.
Penicillin-allergy coverage
Provides Gram-positive and atypical coverage without a beta-lactam ring — a key option when penicillins/cephalosporins can’t be used.

Adverse effects

Most macrolide adverse effects are GI (motility) and the two systemic themes — QT prolongation and CYP3A4-mediated interactions.

Caution: Common
Nausea, vomiting, abdominal cramping, diarrhea (worst with erythromycin); taste changes (clarithromycin).
GI upset is the most common complaint, driven by erythromycin’s motilin (prokinetic) effect. Azithromycin is generally better tolerated.
Warning: Serious Hold & notify
QT prolongation / torsades de pointes; hepatotoxicity/cholestasis; serious drug interactions (erythro/clarithro via CYP3A4); infantile pyloric stenosis (erythromycin in neonates).
QT prolongation can precipitate torsades, especially with other QT drugs or electrolyte disturbance. CYP3A4 inhibition by erythromycin/clarithromycin raises statin (myopathy), warfarin (bleeding), and other drug levels. Clarithromycin is generally avoided in pregnancy.

Interactions

Statins (simvastatin, lovastatin) drug
Erythromycin/clarithromycin inhibit CYP3A4, raising statin levels → myopathy/rhabdomyolysis risk. Azithromycin barely inhibits CYP3A4 — the safer choice when interactions matter.
Warfarin drug
CYP3A4 inhibition (erythromycin/clarithromycin) raises warfarin levels → ↑ INR/bleeding; monitor INR.

Contraindications

The contraindications track the QT and interaction risks.

History of QT prolongation, ventricular arrhythmia, or torsades
Macrolides further prolong the QT interval and can trigger fatal torsades de pointes.
Concurrent strong CYP3A4-dependent drugs (e.g., simvastatin/lovastatin) with erythro/clarithromycin
Blocking their metabolism can raise levels to toxic (e.g., rhabdomyolysis with statins).
Significant hepatic impairment; uncorrected hypokalemia/hypomagnesemia use caution
The liver clears macrolides, and low potassium/magnesium amplifies QT risk.

Nursing considerations

The RN-specific layer — each action paired with the reason it matters.

Monitoring & interactions
Review the full medication list for QT-prolonging and CYP3A4 drugs before starting erythromycin/clarithromycin.
Why: Additive QT effects and blocked metabolism are the main preventable harms; azithromycin is preferred when interactions are a concern.
Assess potassium and magnesium and baseline cardiac risk in at-risk patients.
Why: Electrolyte deficits and cardiac disease magnify the torsades risk.
Patient teaching
Take as directed and complete the course; report palpitations or fainting.
Why: Finishing therapy prevents resistance; palpitations/syncope can signal a QT-related arrhythmia.
Take erythromycin considerations aside, note GI upset is common — report severe or bloody diarrhea (possible C. difficile).
Why: Most GI upset is benign motility, but severe diarrhea may indicate C. difficile colitis.

Sources

Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.